Repeated biopsies in evaluation of therapeutic effects in prostate carcinoma

Prostate

Volumn 49, Issue 2, 2001, Pages 93-100

  Szende, B ^a   Romics, I ^a   Minik, K ^a   Szabo J ^a   Torda, I ^a   Lovasz S ^a   Szomor, L ^a   Toth L ^a   Bely M ^a   Kerenyi T ^a   Bartok K ^a   Vegh A ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Apoptotic and mitotic index; bcl2; Ki67; p53; Prostate carcinoma

Indexed keywords

ANTIANDROGEN; BUSERELIN; GOSERELIN; KI 67 ANTIGEN; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN BCL 2; PROTEIN P53; TRIPTORELIN;

AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MITOSIS INDEX; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BIOPSY; CARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MITOTIC INDEX; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034797097     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.1122     Document Type: Article

References (24)

1. Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma
2. Prognostic markers in clinically localized prostate cancer
3. Grading and scoring in histopathology
4. Prognostic factors in prostate cancer
5. 2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: Relationship with apoptosis and proliferation
6. An evaluation of the markers p53 and Ki67 for their predictive value in prostate cancer
7. Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors
8. Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancer
9. 2, Ki67 and clinical outcome in prostate carcinoma treated by androgen ablation
10. Apoptosis in prostate cancer after hormonal treatment
11. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation
12. Histologic changes in dunning prostate tumors and testes of rats treated with LHRH antagonist SB-75
13. Genitourinary sites. Prostate
14. Cell death: The significance of apoptosis
15. Recent advances in the histopathology and molecular biology of prostate cancer
16. Expression of p21 and mutant p53 gene products in residual prostatic tumor cells after radical radiotherapy
17. Angiogenesis, p53, bcl-2, and Ki67 ion the progression of prostate cancer after radical prostatectomy
18. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: Prognostic significance of p21/WAF1/CIP1 expression
19. Implication of cell kinetic changes during the progression of human prostatic cancer
20. Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki67 labeling index, p53 and bcl-2 immunoreactivity
21. Prognostic significance of bcl-2 in clinically localized prostate cancer
22. The expression of waf-1, p53 and bcl-2 in prostatic adenocarcinoma
23. Immunohistochemical analysis of Ki67 antigen and bcl-2 protein expression in prostatic cancer: Effect of neoadjuvant hormonal therapy
24. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate